Bioceltix S.A. (WSE:BCX)

Bioceltix Balance Sheet

Financials in millions PLN. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	56.83	68.4	33.63	9.31	4.12	6.05
Cash & Short-Term Investments	56.83	68.4	33.63	9.31	4.12	6.05
Cash Growth	89.16%	103.38%	261.24%	125.98%	-31.96%	88.98%
Accounts Receivable	0	-	0	0	0	-
Other Receivables	2.12	2.85	4.98	1.88	0.23	0.44
Receivables	2.12	2.85	4.98	1.88	0.23	0.44
Inventory	-	-	0.01	0.01	-	-
Prepaid Expenses	0.05	0.03	0.02	0.01	0.01	0.01
Other Current Assets	0.07	0.02	0.01	0	1.67	0.01
Total Current Assets	59.07	71.29	38.66	11.21	6.02	6.51
Property, Plant & Equipment	6.22	3.88	2.37	1.48	1.46	1.53
Long-Term Deferred Tax Assets	0.06	0.05	0.03	0.04	0.03	0.02
Other Long-Term Assets	0.37	0.41	0.03	-	0.14	0.14
Total Assets	65.72	75.63	41.09	12.74	7.65	8.2

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1.38	0.64	0.37	1.21	0.96	0.29
Accrued Expenses	0.92	0.77	0.56	0.44	0.34	0.19
Current Portion of Leases	0.13	0.23	0.67	0.1	0.12	0.38
Current Income Taxes Payable	0.64	0.56	0.46	0.36	0.27	0.12
Current Unearned Revenue	-	-	0.01	0.03	0.56	0.93
Total Current Liabilities	3.06	2.19	2.07	2.14	2.25	1.91
Long-Term Leases	0.04	0.09	0.15	0.08	0.18	0.15
Long-Term Unearned Revenue	-	-	-	-	0.03	0.06
Pension & Post-Retirement Benefits	0.02	0.01	0.02	0.01	0.01	0.01
Long-Term Deferred Tax Liabilities	0.08	0.07	0.07	0.04	0.04	0.07
Total Liabilities	3.2	2.36	2.31	2.27	2.5	2.2

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.55	0.55	0.49	0.41	0.34	0.33
Additional Paid-In Capital	72.35	87.52	52.82	23.8	14.44	15.14
Retained Earnings	-10.39	-14.8	-14.54	-13.74	-13.99	-9.47
Comprehensive Income & Other	-	-	-	-	4.36	-
Shareholders' Equity	62.52	73.28	38.78	10.47	5.15	6
Total Liabilities & Equity	65.72	75.63	41.09	12.74	7.65	8.2

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	0.17	0.31	0.82	0.18	0.29	0.53
Net Cash (Debt)	56.66	68.09	32.81	9.14	3.83	5.52
Net Cash Growth	91.49%	107.53%	259.15%	138.76%	-30.74%	72.41%
Net Cash Per Share	10.69	13.62	7.23	2.33	1.15	1.75
Filing Date Shares Outstanding	5.53	5.53	4.92	4.13	3.98	3.29
Total Common Shares Outstanding	5.53	5.53	4.92	4.13	3.43	3.29
Working Capital	56.01	69.1	36.59	9.07	3.78	4.61
Book Value Per Share	11.30	13.25	7.87	2.53	1.50	1.82
Tangible Book Value	62.52	73.28	38.78	10.47	5.15	6
Tangible Book Value Per Share	11.30	13.25	7.87	2.53	1.50	1.82
Buildings	0.35	0.33	0.33	0.33	0.33	0.33
Machinery	0.45	0.41	0.3	0.27	0.24	0.25
Construction In Progress	3.52	1.78	0.1	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Sep 23, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 14, 2026

Data Sources Report a data error